An Oral Whole-Cell Killed Nontypeable Haemophilus influenzae Immunotherapeutic For The Prevention Of Acute Exacerbations Of Chronic Airway Disease

References

• Clancy RL, Murree-Allen K, Cripps AW, Yeung S, Engel M. Oral immunisation with killed haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet. 1985;326:1395–1397. doi:10.1016/S0140-6736(85)92559-0
   Google Scholar
• Craig SW, Cebra JJ. Peyer’s patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med. 1971;134:188–200. doi:10.1084/jem.134.1.1884934147
   PubMed Web of Science ®Google Scholar
• Rudzik R, Clancy RL, Perey DYE, Day RP, Bienenstock J. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous Peyer’s patch and bronchial lymphocytes. J Immunol. 1975;114:1599–1604.1091707
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol. 2008;1:31–37. doi:10.1038/mi.2007.919079158
   PubMed Web of Science ®Google Scholar
• Clancy RL, Bienenstock J. The proliferative response of bronchus-associated lymphoid tissue after local and systemic immunization. J Immunol. 1974;112:1997–2001.4133074
   PubMed Web of Science ®Google Scholar
• Wallace FJ, Clancy RL, Cripps AW. An animal model demonstration of enhanced clearance of nontypable haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue. Am Rev Respir Dis. 1989;140:311–316. doi:10.1164/ajrccm/140.2.3112788377
   PubMed Web of Science ®Google Scholar
• Husband AJ, Dunkley ML, Cripps AW, Clancy RL. Antigen-specific response among T lymphocytes following intestinal administration of alloantigens. Aust J Exp Biol Med Sci. 1984;62:687–699. doi:10.1038/icb.1984.656241823
   PubMedGoogle Scholar
• Scicchitano R, Husband AJ, Clancy RL. Contribution of intraperitoneal immunization to the local immune response in the respiratory tract of sheep. Immunology. 1984;53:375–384. doi:10.1164/arrd.1978.117.3.5136490090
   PubMed Web of Science ®Google Scholar
• Clancy RL, Pucci A, Jelihovsky T, Bye P. Immunologic “memory” for microbial antigens in lymphocytes obtained from human bronchial mucosa 1–3. Am Rev Respir Dis. 1978;117:513–518. doi:10.1164/arrd.1978.117.3.513204236
   PubMed Web of Science ®Google Scholar
• Anthonisen NR. The British hypothesis revisited. Eur Respir J. 2004;23:657–658. doi:10.1183/09031936.04.0001300415176673
   PubMed Web of Science ®Google Scholar
• Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361:449–456. doi:10.1016/S0140-6736(03)12459-212583942
   PubMed Web of Science ®Google Scholar
• Tandon MK, Gebski V. A controlled trial of a killed haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis. Intern Med J. 1991;21:427–432.
   Google Scholar
• Lehmann D, Coakley KJ, Coakley CA, et al. Reduction in the incidence of acute bronchitis by an oral haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am J Respir Crit Care Med. 1991;144:324–330.
   PubMed Web of Science ®Google Scholar
• Clancy RL, Cripps AW, Pang G, Yeung S, Murree-Allen K. The paradox of immunization against haemophilus influenzae-related endobronchitis: protection restricted to ingestion of’non-adjuvenated’vaccine. Adv Exp Med Biol. 1986;216:1759–1764.
   Google Scholar
• Clancy RL, Cripps AW, Husband AJ, Buckley D. Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine. Infect Immun. 1983;39:491–496.6339379
   PubMed Web of Science ®Google Scholar
• Otczyk DC, Clancy RL, Cripps AW. Haemophilus influenzae and smoking-related obstructive airways disease. Int J Chron Obstruct Pulmon Dis. 2011;6:345–351. doi:10.2147/COPD.S1935921760721
   PubMed Web of Science ®Google Scholar
• Wallace FJ, Cripps AW, Clancy RL, Husband AJ, Witt CS. A role for intestinal T lymphocytes in bronchus mucosal immunity. Immunology. 1991;74:68–73.1937575
   PubMed Web of Science ®Google Scholar
• Clancy RL, Dunkley ML. Acute exacerbations in COPD and their control with oral immunization with non-typeable haemophilus influenzae. Front Immunol. 2011;2:1–6. doi:10.3389/fimmu.2011.0000722566792
   PubMed Web of Science ®Google Scholar
• Pang G, Ortega M, Zighang R, Reeves G, Clancy RL. Autocrine modulation of IL-8 production by sputum neutrophils in chronic bronchial sepsis. Am J Respir Crit Care Med. 1997;155:726–731. doi:10.1164/ajrccm.155.2.90322199032219
   PubMed Web of Science ®Google Scholar
• Clancy RL, Dunkley ML. Oral non‐typable haemophilus influenzae enhances physiological mechanism of airways protection. Clin Exp Immunol. 2010;161:127–133. doi:10.1111/j.1365-2249.2010.04142.x20408861
   PubMed Web of Science ®Google Scholar
• Dunkley ML, Husband AJ, Beagley KW, Clancy RL, Collins AM, Cripps AW, Emery DL,. A rodent model of concurrent respiratory infection with influenza virus and gram-negative bacteria: synergistic infection and protection by oral immunization In: Mucosal Solutions: Advances in Mucosal Immunology. Vol. 1 University of Sydney, Sydney Australia. 1997;261–268.
   Google Scholar
• Kopf M, Schneider C, Nobs SP. The development and function of lung-resident macrophages and dendritic cells. Nat Immunol. 2015;16:36–44. doi:10.1038/ni.305225521683
   PubMed Web of Science ®Google Scholar
• Clancy RL. Towards a vaccine for chronic obstructive pulmonary disease. Intern Med J. 2012;42:607–613. doi:10.1111/j.1445-5994.2012.02752.x22372964
   PubMed Web of Science ®Google Scholar
• Tandon MK, Phillips M, Waterer G, Dunkley ML, Comans P, Clancy RL. Oral immunotherapy with inactivated nontypeable haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest. 2010;137:805–811. doi:10.1378/chest.09-138219952063
   PubMed Web of Science ®Google Scholar
• Clancy RL, Dunkley ML, Sockler J, McDonald CF. Multi‐site placebo‐controlled randomised clinical trial to assess protection following oral immunisation with inactivated non‐typeable haemophilus influenzae in chronic obstructive pulmonary disease. Internal Medicine Journal. 2016;46:684–693. doi:10.1111/imj.1307227009822
   PubMed Web of Science ®Google Scholar
• Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481–504. doi:10.1146/annurev-physiol-021115-10523826527186
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–645. doi:10.1056/NEJMoa131572725119609
   PubMed Web of Science ®Google Scholar
• Grimwood K, Kyd JM, Owen SJ, Massa HM, Cripps AW. Vaccination against respiratory pseudomonas aeruginosa infection. Hum Vaccin Immunother. 2015;11:14–20. doi:10.4161/hv.3429625483510
   PubMed Web of Science ®Google Scholar